These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23016640)

  • 1. Adsorptive-mediated brain delivery systems.
    Lu W
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2340-8. PubMed ID: 23016640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS delivery via adsorptive transcytosis.
    Hervé F; Ghinea N; Scherrmann JM
    AAPS J; 2008 Sep; 10(3):455-72. PubMed ID: 18726697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis.
    Thomsen LB; Lichota J; Eskehave TN; Linemann T; Mortensen JH; du Jardin KG; Moos T
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2349-54. PubMed ID: 23016641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
    Li Y; Zheng X; Gong M; Zhang J
    Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
    Zhou X; Smith QR; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
    Zhang W
    Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.
    Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE
    Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.
    Lin KH; Hong ST; Wang HT; Lo YL; Lin AM; Yang JC
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.
    Ruiz-López E; Schuhmacher AJ
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery across the blood brain barrier in Alzheimer's disease.
    Rocha S
    Curr Pharm Des; 2013; 19(37):6635-46. PubMed ID: 23621533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches for drug delivery to central nervous system.
    Hossain S; Akaike T; Chowdhury EH
    Curr Drug Deliv; 2010 Dec; 7(5):389-97. PubMed ID: 20950269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
    Lu W; Sun Q; Wan J; She Z; Jiang XG
    Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.